Restricted accessResearch articleFirst published online 2015-04
Increased Culture Density Is Linked to Decelerated Proliferation,Prolonged G 1 Phase,and Enhanced Propensity for Differentiation of Self-Renewing Human Pluripotent Stem Cells
Human pluripotent stem cells (hPSCs) display a very short G1 phase and rapid proliferation kinetics. Regulation of the cell cycle, which is linked to pluripotency and differentiation, is dependent on the stem cell environment, particularly on culture density. This link has been so far empirical and central to disparities in the growth rates and fractions of self-renewing hPSCs residing in different cycle phases. In this study, hPSC cycle progression in conjunction with proliferation and differentiation were comprehensively investigated for different culture densities. Cell proliferation decelerated significantly at densities beyond 50×104 cells/cm2. Correspondingly, the G1 fraction increased from 25% up to 60% at densities greater than 40×104 cells/cm2 while still hPSC pluripotency marker expression was maintained. In parallel, expression of the cycle inhibitor CDKN1A (p21) was increased, while that of p27 and p53 did not change significantly. After 4 days of culture in an unconditioned medium, greater heterogeneity was noted in the differentiation outcomes and was limited by reducing the density variation. A quantitative model was constructed for self-renewing and differentiating hPSC ensembles to gain a better understanding of the link between culture density, cycle progression, and stem cell state. Results for multiple hPSC lines and medium types corroborated experimental findings. Media commonly used for maintenance of self-renewing hPSCs exhibited the slowest kinetics of induction of differentiation (kdiff), while BMP4 supplementation led to 14-fold higher kdiff values. Spontaneous differentiation in a growth factor-free medium exhibited the largest variation in outcomes at different densities. In conjunction with the quantitative framework, our findings will facilitate rationalizing the selection of cultivation conditions for the generation of stem cell therapeutics.
Get full access to this article
View all access options for this article.
References
1.
BeckerKA, GhulePN, TherrienJA, LianJB, SteinJL, van WijnenAJ and SteinGS. (2006). Self-renewal of human embryonic stem cells is supported by a shortened G1 cell cycle phase. J Cell Physiol, 209:883–893.
2.
SalomoniP and CalegariF. (2010). Cell cycle control of mammalian neural stem cells: putting a speed limit on G1. Trends Cell Biol, 20:233–243.
3.
BeckerKA, SteinJL, LianJB, van WijnenAJ and SteinGS. (2010). Human embryonic stem cells are pre-mitotically committed to self-renewal and acquire a lengthened G1 phase upon lineage programming. J Cell Physiol, 222:103–110.
4.
FilipczykAA, LaslettAL, MummeryC and PeraMF. (2007). Differentiation is coupled to changes in the cell cycle regulatory apparatus of human embryonic stem cells. Stem Cell Res, 1:45–60.
5.
SelaY, MolotskiN, GolanS, Itskovitz-EldorJ and SoenY. (2012). Human embryonic stem cells exhibit increased propensity to differentiate during the G1 phase prior to phosphorylation of retinoblastoma protein. Stem Cells, 30:1097–1108.
6.
FuchsE. (2009). The tortoise and the hair: slow-cycling cells in the stem cell race. Cell, 137:811–819.
7.
NeganovaI, VilellaF, AtkinsonSP, LloretM, PassosJF, von ZglinickiT, O'ConnorJE, BurksD, JonesR, ArmstrongL and LakoM. (2011). An Important role for CDK2 in G1 to S checkpoint activation and DNA damage response in human embryonic stem cells. Stem Cells, 29:651–659.
8.
KallasA, PookM, MaimetsM, ZimmermannK and MaimetsT. (2011). Nocodazole treatment decreases expression of pluripotency markers Nanog and Oct4 in human embryonic stem cells. PloS One, 6:e19114.
9.
ZhangX, NeganovaI, PrzyborskiS, YangCB, CookeM, AtkinsonSP, AnyfantisG, FenykS, KeithWN, et al. (2009). A role for NANOG in G1 to S transition in human embryonic stem cells through direct binding of CDK6 and CDC25A. J Cell Biol, 184:67–82.
10.
SeguinCA, DraperJS, NagyA and RossantJ. (2008). Establishment of endoderm progenitors by SOX transcription factor expression in human embryonic stem cells. Cell Stem Cell, 3:182–195.
11.
MelkoumianZ, WeberJL, WeberDM, FadeevAG, ZhouYE, Dolley-SonnevilleP, YangJW, QiuLQ, PriestCA, et al. (2010). Synthetic peptide-acrylate surfaces for long-term self-renewal and cardiomyocyte differentiation of human embryonic stem cells. Nat Biotechnol, 28:606–610.
12.
XuRH, PeckRM, LiDS, FengXZ, LudwigT and ThomsonJA. (2005). Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells. Nat Methods, 2:185–190.
13.
PolyakK, KatoJY, SolomonMJ, SherrCJ, MassagueJ, RobertsJM and KoffA. (1994). P27(Kip1), a cyclin-Cdk inhibitor, links transforming growth-factor-beta and contact inhibition to cell-cycle arrest. Gene Dev, 8:9–22.
14.
ChettyS, PagliucaFW, HonoreC, KweudjeuA, RezaniaA and MeltonDA. (2013). A simple tool to improve pluripotent stem cell differentiation. Nat Methods, 10:553–556.
15.
D'AmourKA, AgulnickAD, EliazerS, KellyOG, KroonE and BaetgeEE. (2005). Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat Biotechnol, 23:1534–1541.
16.
MurryCE and KellerG. (2008). Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell, 132:661–680.
17.
RoccioM, SchmitterD, KnoblochM, OkawaY, SageD and LutolfMP. (2013). Predicting stem cell fate changes by differential cell cycle progression patterns. Development, 140:459–470.
18.
BauwensCL, PeeraniR, NiebrueggeS, WoodhouseKA, KumachevaE, HusainM and ZandstraPW. (2008). Control of human embryonic stem cell colony and aggregate size heterogeneity influences differentiation trajectories. Stem Cells, 26:2300–2310.
19.
KehoeDE, JingD, LockLT and TzanakakisEM. (2010). Scalable stirred-suspension bioreactor culture of human pluripotent stem cells. Tissue Eng Part A, 16:405–421.
20.
RodriguesCA, FernandesTG, DiogoMM, da SilvaCL and CabralJM. (2011). Stem cell cultivation in bioreactors. Biotechnol Adv, 29:815–829.
21.
LockLT and TzanakakisES. (2009). Expansion and differentiation of human embryonic stem cells to endoderm progeny in a microcarrier stirred-suspension culture. Tissue Eng Part A, 15:2051–2063.
22.
YuanJS, ReedA, ChenF and StewartCN. (2006). Statistical analysis of real-time PCR data. BMC Bioinformatics, 7:85.
23.
WuJ and TzanakakisES. (2012). Contribution of stochastic partitioning at human embryonic stem cell division to NANOG heterogeneity. PloS One, 7:e50715.
24.
OrfordKW and ScaddenDT. (2008). Deconstructing stem cell self-renewal: genetic insights into cell-cycle regulation. Nat Rev Genet, 9:115–128.
25.
PauklinS and VallierL. (2013). The cell-cycle state of stem cells determines cell fate propensity. Cell, 155:135–147.
26.
WuJ and TzanakakisES. (2013). Distinct allelic patterns of nanog expression impart embryonic stem cell population heterogeneity. PLoS Comput Biol, 9:e1003140.
27.
GeisserS. (1975). The predictive sample reuse method with applications. J Am Stat Assoc, 70:320–328.
28.
MenchonC, EdelMJ and BelmonteJCI. (2011). The cell cycle inhibitor p27(Kip1) controls self-renewal and pluripotency of human embryonic stem cells by regulating the cell cycle, Brachyury and Twist. Cell Cycle, 10:1435–1447.
29.
RuizS, PanopoulosAD, HerreriasA, BissigKD, LutzM, BerggrenWT, VermaIM and BelmonteJCI. (2011). A high proliferation rate is required for cell reprogramming and maintenance of human embryonic stem cell identity. Curr Biol, 21:45–52.
30.
LinTX, ChaoC, SaitoS, MazurSJ, MurphyME, AppellaE and XuY. (2005). P53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nat Cell Biol, 7:165–171.
31.
QinH, YuTX, QingTT, LiuYX, ZhaoY, CaiJ, LiJ, SongZH, et al. (2007). Regulation of apoptosis and differentiation by p53 in human embryonic stem cells. J Biol Chem, 282:5842–5852.
YuPZ, PanGJ, YuJY and ThomsonJA. (2011). FGF2 sustains NANOG and switches the outcome of BMP4-induced human embryonic stem cell differentiation. Cell Stem Cell, 8:326–334.
FanY, HsiungM, ChengC and TzanakakisES. (2014). Facile engineering of xeno-free microcarriers for the scalable cultivation of human pluripotent stem cells in stirred suspension. Tissue Eng Part A, 20:588–599.
36.
KehatI, Kenyagin-KarsentiD, SnirM, SegevH, AmitM, GepsteinA, LivneE, BinahO, Itskovitz-EldorJ and GepsteinL. (2001). Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest, 108:407–414.
37.
Werbowetski-OgilvieTE, BosseM, StewartM, SchnerchA, Ramos-MejiaV, RouleauA, WynderT, SmithMJ, DingwallS, et al. (2009). Characterization of human embryonic stem cells with features of neoplastic progression. Nat Biotechnol, 27:91–97.
38.
BartaT, DolezalovaD, HolubcovaZ and HamplA. (2013). Cell cycle regulation in human embryonic stem cells: links to adaptation to cell culture. Exp Biol Med, 238:271–275.
39.
HatanoS, TadaM, KimuraH, YamaguchiS, KonoT, NakanoT, SuemoriH, NakatsujiN and TadaT. (2005). Pluripotential competence of cells associated with Nanog activity. Mech Dev, 122:67–79.
40.
LohYH, WuQ, ChewJL, VegaVB, ZhangWW, ChenX, BourqueG, GeorgeJ, LeongB, et al. (2006). The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet, 38:431–440.
41.
MitsuiK, TokuzawaY, ItohH, SegawaK, MurakamiM, TakahashiK, MaruyamaM, MaedaM and YamanakaS. (2003). The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell, 113:631–642.
42.
RamakrishnaS, SureshB, LimKH, ChaBH, LeeSH, KimKS and BaekKH. (2011). PEST motif sequence regulating human NANOG for proteasomal degradation. Stem Cells Dev, 20:1512–1520.
43.
ChaeHD, LeeMR and BroxmeyerHE. (2012). 5-Aminoimidazole-4-carboxyamide ribonucleoside induces G(1)/S arrest and Nanog downregulation via p53 and enhances erythroid differentiation. Stem Cells, 30:140–149.
44.
KalmarT, LimC, HaywardP, Munoz-DescalzoS, NicholsJ, Garcia-OjalvoJ and Martinez AriasA. (2009). Regulated fluctuations in nanog expression mediate cell fate decisions in embryonic stem cells. Plos Biol, 7:e1000149.
45.
MiyanariY and Torres-PadillaME. (2012). Control of ground-state pluripotency by allelic regulation of Nanog. Nature, 483:470–473.
46.
FaddahDA, WangH, ChengAW, KatzY, BuganimY and JaenischR. (2013). Single-cell analysis reveals that expression of nanog is biallelic and equally variable as that of other pluripotency factors in mouse ESCs. Cell Stem Cell, 13:23–29.
47.
FilipczykA, GkatzisK, FuJ, HoppePS, LickertH, AnastassiadisK and SchroederT. (2013). Biallelic expression of nanog protein in mouse embryonic stem cells. Cell Stem Cell, 13:12–13.
48.
LuR, MarkowetzF, UnwinRD, LeekJT, AiroldiEM, MacArthurBD, LachmannA, RozovR, Ma'ayanA, et al. (2009). Systems-level dynamic analyses of fate change in murine embryonic stem cells. Nature, 462:358–362.
49.
ZhangYS, SevillaA, WanLQ, LemischkaIR and Vunjak-NovakovicG. (2013). Patterning pluripotency in embryonic stem cells. Stem Cells, 31:1806–1815.
50.
CheungTH and RandoTA. (2013). Molecular regulation of stem cell quiescence. Nature reviews. Mol Cell Biol, 14:329–340.
MacleodKF, SherryN, HannonG, BeachD, TokinoT, KinzlerK, VogelsteinB and JacksT. (1995). p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev, 9:935–944.
53.
PonzioG, LoubatA, RochetN, TurchiL, RezzonicoR, Farahi FarD, DulicV and RossiB. (1998). Early G1 growth arrest of hybridoma B cells by DMSO involves cyclin D2 inhibition and p21[CIP1] induction. Oncogene, 17:1159–1166.
54.
ChangHH, HembergM, BarahonaM, IngberDE and HuangS. (2008). Transcriptome-wide noise controls lineage choice in mammalian progenitor cells. Nature, 453:544–547.
55.
TysonDR, GarbettSP, FrickPL and QuarantaV. (2012). Fractional proliferation: a method to deconvolve cell population dynamics from single-cell data. Nat Methods, 9:923–928.
56.
WuJ, RostamiMR and TzanakakisES. (2013). Stem cell modeling: from gene networks to cell populations. Curr Opin Chem Eng, 2:17–25.
57.
WuJ and TzanakakisES. (2013). Deconstructing stem cell population heterogeneity: single-cell analysis and modeling approaches. Biotechnol Adv, 31:1047–1062.
58.
McLeanAB, D'AmourKA, JonesKL, KrishnamoorthyM, KulikMJ, ReynoldsDM, SheppardAM, LiuHQ, XuY, BaetgeEE and DaltonS. (2007). Activin a efficiently specifies definitive endoderm from human embryonic stem cells only when phosphatidylinositol 3-kinase signaling is suppressed. Stem Cells, 25:29–38.
59.
SinghAM, ReynoldsD, CliffT, OhtsukaS, MattheysesAL, SunY, MenendezL, KulikM and DaltonS. (2012). Signaling network crosstalk in human pluripotent cells: a Smad2/3-regulated switch that controls the balance between self-renewal and differentiation. Cell Stem Cell, 10:312–326.
60.
BrownS, TeoA, PauklinS, HannanN, ChoCH, LimB, VardyL, DunnNR, TrotterM, PedersenR and VallierL. (2011). Activin/nodal signaling controls divergent transcriptional networks in human embryonic stem cells and in endoderm progenitors. Stem Cells, 29:1176–1185.
61.
JingDH, ParikhA and TzanakakisES. (2010). Cardiac cell generation from encapsulated embryonic stem cells in static and scalable culture systems. Cell Transplant, 19:1397–1412.
62.
MorchainJ, GabelleJC and CockxA. (2013). Coupling of biokinetic and population balance models to account for biological heterogeneity in bioreactors. AIChE J, 59:369–379.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
